Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: A liquid biopsy signature of circulating extracellular vesicles-derived RNAs predicts response to first line chemotherapy in patients with metastatic colorectal cancer

Fig. 2

Predictive ability of the 22-gene signature in different cohort. The ROC analyses illustrated the predictive ability of this 22-gene model to identify responders in the training set (A), internal validation set (B), and external validation set (C); The scores of enrolled patients in different cohorts which were calculated based on the 22-gene signature: the training cohort (D), the internal validation cohort (E), the external validation cohort (F), the cohort combined chemotherapy with anti-EGFR (G), the cohort combined chemotherapy with anti-VEGF (H). Patients with lower risk score would more likely obtain tumor remission in training group (I), internal validation group (J) and external validation group (K)

Back to article page

Molecular Cancer

ISSN: 1476-4598